case_images: PMC4929381_01
case_images: Abdominal computed tomography at the first administration. a A 4.2-cm multilocular cystic mass (arrowhead) was observed in the pancreatic head. b A 4.6-cm solid mass (arrow) was detected in the pancreatic tail.
case_images: crg-0010-0075-g01.jpg
case_images: PMC4929381_01_crg-0010-0075-g01.jpg
case_images: F1
case_images: Computed tomography revealed a 4.6-cm solid mass in the pancreatic tail with ring enhancement and a 4.2-cm multilocular cystic mass in the pancreatic head (fig. 1).
case_images: Abdominal computed tomography 1 month after the first administration revealed two solid masses in the gastric wall of the antrum (a, arrowhead) and the upper body (b, arrow).
case_images: crg-0010-0075-g02.jpg
case_images: PMC4929381_01_crg-0010-0075-g02.jpg
case_images: F2
case_images: Both of them were separated from the primary pancreatic cancer and seemed to be located in the submucosal layer (fig. 2).
case_images: Esophagogastroduodenoscopy revealed a submucosal tumor with normal mucosa in the posterior wall of the upper body of the stomach, suggesting the gastric hematogenous metastasis of pancreatic cancer.
case_images: crg-0010-0075-g03.jpg
case_images: PMC4929381_01_crg-0010-0075-g03.jpg
case_images: F3
case_images: Esophagogastroduodenoscopy revealed a submucosal tumor with normal mucosa in the posterior wall of the upper body of the stomach, suggesting the gastric hematogenous metastasis of pancreatic cancer (fig. 3).